Topical Hemostatic Agents in Minimally Invasive Surgery: A Team Approach
Premiere Date: Thursday, December 16, 2021This activity offers CE credit for:
- ABIM (MOC)
- ABS (CC)
- Medicine (accme)
- Nursing (ANCC)
- Pharmacy (acpe)
- Other
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Friday, December 16, 2022
Note: Credit Is No Longer Available
| Patricia C. Chui, MD, PhD (Moderator) Assistant Professor of Surgery New York University Langone Medical Center Director of Bellevue Hernia Center Bellevue Hospital New York, NY |
| Michelle Olivo, RN, BSN, CNOR Operating Room Staff Nurse Bellevue Hospital Center HHC New York, NY |
| Julia Park, MD Assistant Professor Department of Surgery NYU Grossman School of Medicine Bellevue Hospital New York, NY |
Control of hemostasis is critical to the success of surgical interventions and is an important strategy to reduce complications or risks due to the adverse side effects of blood transfusions. In contemporary minimally invasive surgery (MIS), including robotic surgery, advances in instrumentation and surgical skills allow more types of operations to be performed through smaller incisions. While restricted access to an operative site can limit the use of some tools, a variety of topical hemostats can now be successfully deployed in MIS procedures, including operations with difficult to reach and/or poorly visualized areas.
To optimize patient outcomes, it is important that surgical teams are up to date on how to safely prepare, administer, and monitor several categories of topical hemostatic agents that are indicated for use in MIS. This CMEOutfitters Live and OnDemand education initiative features presentations, discussions, and demonstrations by an active perioperative MIS team.
At the end of this CE activity, participants should be able to:
- Evaluate the role of topical hemostatic agents in minimally invasive surgery (MIS) procedures.
- Prepare topical hemostatic agents in the operating room environment for use in MIS.
- Implement strategies to control bleeding in MIS using topical hemostatic agents.
Supported by an educational grant from Pfizer Inc.
Surgeons and other health care professionals involved in performing minimally invasive (including robotically-assisted) procedures
ABIM MOC Credit:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Learning Formats
Enduring material
Royal College MOC:
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME's "CME in Support of MOC" program in Section 3 of the Royal College's MOC Program.
MIPS Improvement Activity:
This activity counts towards MIPS Improvement Activity requirements under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.
Disclosure Declaration
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Chui has no disclosures to report.
Ms. Olivo has no disclosures to report.
Dr. Park has no disclosures to report.
Michael Franks, APRN, AGACNP-BC, FNP-BC (peer reviewer) has no disclosures to report.
Kathleen Blake, PhD (planning committee) has no disclosures to report.
Warren Beckman (planning committee) has no disclosure to report.
Jan Perez (planning committee) has no disclosures to report.
Sharon Tordoff (planning committee) has no disclosures to report.
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).
TV-141-121621-02
